We provide you with 20 years of free, institutional-grade data for ICLR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ICLR. Explore the full financial landscape of ICLR stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Clerkin Nigel Bernard John | Initial | 2026-03-18 | |||
| Cutler Stephen A | Initial | 2026-03-18 | |||
| Grais Linda | Initial | 2026-03-18 | |||
| Lyons Emer | Initial | 2026-03-18 | |||
| O'Neill Julie | Initial | 2026-03-18 | |||
| McCague Eugene Pacelli | Initial | 2026-03-18 | |||
| Murphy Ronan Martin | Initial | 2026-03-18 | |||
| CLIMAX JOHN DR | Initial | 2026-03-18 | |||
| Murray Ciaran | Initial | 2026-03-18 | |||
| Balfe Barry Edward | Initial | 2026-03-18 |
The information provided in this report about ICLR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ICON Public Limited Company(NASDAQ:ICLR) 
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support va...
Website: http://www.iconplc.com
Founded: 1990
Full Time Employees: 15,250
Sector: Healthcare
Industry: Diagnostics & Research